Continuous glucose monitoring: Changing Diabetes behavior in real time and retrospectively

Journal of Diabetes Science and Technology

Volumn 2, Issue 3, 2008, Pages 484-489

  Block, Jennifer M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Behavior modification; Continuous glucose monitors; Glucose trends; Real time; Retrospective

Indexed keywords

EID: 78650863791     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200320     Document Type: Article

References (15)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
2. U. K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
3. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fuctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.
4. Monnier L, Colette C, Leiter L, Ceriello A, Hanefield M, Owens D, Tajima N, Tuomiletho J, Davidson J; PGR Group. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2007;30(1):185-6.
5. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178-81.
6. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes. 2005;54(1):1-7.
7. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefield M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23(12):1830-4.
8. Voskanyan G, Keenan B, Mastrototaro JJ, Steil GM. Putative delays in interstitial fuid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself. J Diabetes Sci Technol. 2007;1(5):639-44.
9. Thompson CJ, Cummings JF, Chalmers J, Gould C, Newton RW. How have patients reacted to the implications of the DCCT? Diabetes Care. 1996;19(8):876-9.
10. Wolpert HA. Use of continuous glucose monitoring in the detection and prevention of hypoglycemia. J Diabetes Sci Technol. 2007;1(1):146-50.
11. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50.
12. ® continuous glucose monitoring system. Proceedings of the 42nd European Association for the Studies of Diabetes Meeting; 2006 Sep. 14-17; Copenhagen, Denmark.
13. Deiss D, Bolinder J, Rivelene JP, Battelino T, Bosi E, Tubiana-Ruf N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2.
14. Diabetes Research in Children Network (DirecNet) Study Group, Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr. 2007;151(4):388-93.
15. Anderson B, Funnell M. The art of empowerment: stories and strategies for diabetes educators. Alexandria (VA): The American Diabetes Association; 2000.